We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+6.3%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$31.9B
AUM Growth
+$1.95B
(+6.5%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
2,075
New
328
Increased
694
Reduced
841
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$152M |
| 2 |
Ventas
VTR
|
+$139M |
| 3 |
Williams Companies
WMB
|
+$122M |
| 4 |
Healthpeak Properties
DOC
|
+$100M |
| 5 |
Chevron
CVX
|
+$78.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$276M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$110M |
| 3 |
Fortune Brands Innovations
FBIN
|
+$84.2M |
| 4 |
AGN
Allergan Inc
AGN
|
+$73.4M |
| 5 |
Morgan Stanley
MS
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.93% |
| 2 | Consumer Staples | 12.47% |
| 3 | Energy | 12.35% |
| 4 | Financials | 8.98% |
| 5 | Utilities | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GM.WS.B
926
DELISTED
General Motors Company
GM.WS.B
| $2.17M | 0.01% |
116,802
| – | – |
|
927
Knowles
KN
$3B
| $2.16M | 0.01% |
70,316
-1,250
| -2% | -$37.8K |
|
928
Charles River Laboratories
CRL
$13.1B
| $2.16M | 0.01% |
40,383
+9,066
| +29% | +$497K |
|
|
AOL
929
DELISTED
AOL INC COMMON STOCK
AOL
| $2.13M | 0.01% |
53,619
-9,893
| -16% | -$390K |
|
930
KBR
KBR
$4.61B
| $2.13M | 0.01% |
89,453
-10,667
| -11% | -$268K |
|
|
FNFG
931
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $2.12M | 0.01% |
243,083
+17,814
| +8% | +$158K |
|
|
URS
932
DELISTED
URS CORP
URS
| $2.12M | 0.01% |
46,178
-2,947
| -6% | -$136K |
|
|
ULTI
933
DELISTED
Ultimate Software Group Inc
ULTI
| $2.12M | 0.01% |
15,315
+388
| +3% | +$49.3K |
|
934
Fortinet
FTNT
$126B
| $2.08M | 0.01% |
414,920
-51,875
| -11% | -$232K |
|
935
First American
FAF
$7.26B
| $2.08M | 0.01% |
74,900
+17,577
| +31% | +$479K |
|
936
WEX
WEX
$6.72B
| $2.06M | 0.01% |
19,677
-277
| -1% | -$26.5K |
|
937
Colgate-Palmolive
CL
$69.4B
| $2.06M | 0.01% |
30,192
+833
| +3% | +$55.8K |
|
|
NATI
938
DELISTED
National Instruments Corp
NATI
| $2.06M | 0.01% |
63,503
+815
| +1% | +$23.4K |
|
|
SJR
939
DELISTED
Shaw Communications Inc.
SJR
| $2.05M | 0.01% |
79,866
+29,158
| +58% | +$717K |
|
|
TIBX
940
DELISTED
TIBCO SOFTWARE INC
TIBX
| $2.04M | 0.01% |
101,240
-2,558
| -2% | -$51K |
|
941
Carpenter Technology
CRS
$20.4B
| $2.03M | 0.01% |
32,162
+5,699
| +22% | +$362K |
|
942
Accenture
ACN
$116B
| $2.03M | 0.01% |
25,123
-5,623
| -18% | -$451K |
|
|
VIRX
943
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.03M | 0.01% |
1,480
-782
| -35% | -$907K |
|
944
Capri Holdings
CPRI
$1.67B
| $2.02M | 0.01% |
22,841
+4,858
| +27% | +$446K |
|
|
MON
945
DELISTED
Monsanto Co
MON
| $2.02M | 0.01% |
16,239
-3,470
| -18% | -$406K |
|
|
ESND
946
DELISTED
Essendant Inc.
ESND
| $2.02M | 0.01% |
48,760
-239
| -0.5% | -$9.37K |
|
947
Lazard
LAZ
$3.57B
| $2.02M | 0.01% |
39,148
+2,661
| +7% | +$131K |
|
948
Simon Property Group
SPG
$65.7B
| $2.02M | 0.01% |
12,137
-705
| -5% | -$115K |
|
949
Criteo S.A.
CRTO
$838M
| $2.01M | 0.01% |
59,429
+21,000
| +55% | +$701K |
|
|
RVBD
950
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $2M | 0.01% |
97,105
-6,995
| -7% | -$138K |
|
Similar funds
Federated Hermes's Q2 2014 Portfolio in Review
As of Q2 2014, Federated Hermes held 2,075 positions worth $31.9B, up 6.5% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Federated Hermes's Q2 2014 filing shows 328 new, 694 increased, 841 reduced and 117 closed positions. Its largest new stake was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M. The largest sale was AstraZeneca, an estimated $276M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.
- Federated Hermes's largest Q2 2014 buy was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M.
- Federated Hermes added most to Illumina in Q2 2014, an estimated $152M increase.
- Federated Hermes's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $276M.
- Federated Hermes fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q2 2014, selling an estimated $39.7M.
- Federated Hermes's ten largest holdings make up 20% of its $31.9B portfolio in Q2 2014.
- Federated Hermes opened 328 new positions and closed 117 in Q2 2014.
- Federated Hermes's portfolio value rose 6.5% quarter-over-quarter to $31.9B.
Based on Federated Hermes's 13F filing for Q2 2014, filed 7 Aug 2014.